Souhaitez-vous accéder aux communiqués récents ?

LAWRENCEVILLE, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, announces that the Company...

SAN DIEGO, May 05, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer,...

ANOTHER QUARTER OF STRONG MIX - 2026 GUIDANCE CONFIRMED Net revenues of Euro 1,848 million, up 3% versus prior year (up 6% at constant currency(1)) Operating profit (EBIT)(1) of Euro 548 million,...

onsemi (the “Company”) (Nasdaq: ON) today announced its first quarter 2026 earnings results.

COPENHAGEN, Denmark, May 4, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, will provide a...

SBC Medical Group Holdings Inc will announce first quarter 2026 financial results on May 14, 2026.

Highlights(1) Delivered strong first-quarter 2026 results, reflecting sales growth, disciplined execution, and improved operating performance. Sales increased 3% to $10.4 billion, despite a 7%...

Mdxhealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will release its financial results for the first quarter ended Mar

AC Immune First Quarter 2026 Financial and Corporate Updates Dosed first subjects in Phase 1 trial of brain-penetrant small molecule NLRP3 inhibitor ACI-19764 with SAD/MAD results in healthy...

Company generates revenue growth for second consecutive quarter driven by retail performance and announces $20 million share repurchase authorization CHICAGO, April 30, 2026 (GLOBE NEWSWIRE) --...